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ABSTRACT
Objectives: To analyse how comorbidity among
patients with back pain, depression and osteoarthritis
inﬂuences healthcare costs per patient. A special focus
was made on the distribution of costs for primary
healthcare compared with specialist care, hospital care
and drugs.
Design: Population-based cross-sectional study.
Setting: The County of O ¨stergo ¨tland, Sweden.
Patients: Data on diagnoses and healthcare costs for
all 266354 individuals between 20 and 75 years of
age, who were residents of the County of O ¨stergo ¨tland,
Sweden, in the year 2006, were extracted from the
local healthcare register and the national register of
drug prescriptions.
Main outcome measures: The effects of
comorbidity on healthcare costs were estimated as
interactions in regression models that also included
age, sex, number of other health conditions and
education.
Results: The largest diagnosed group was back pain
(11178 patients) followed by depression (7412
patients) and osteoarthritis (5174 patients). The largest
comorbidity subgroup was the combination of back
pain and depression (772 patients), followed by the
combination of back pain and osteoarthritis (527
patients) and the combination of depression and
osteoarthritis (206 patients). For patients having both
a depression diagnosis and a back pain diagnosis, there
was a signiﬁcant negative interaction effect on total
healthcare costs. The average healthcare costs among
patients with depression and back pain was SEK 11806
lower for a patient with both diagnoses. In this
comorbidity group, there were tendencies of
a positive interaction for general practitioner visits
and negative interactions for all other visits and
hospital days. Small or no interactions at all were seen
between depression diagnoses and osteoarthritis
diagnoses.
Conclusions: A small increase in primary healthcare
visits in comorbid back pain and depression patients
was accompanied with a substantial reduction in total
healthcare costs and in hospital costs. Our results can
be of value in analysing the cost effects of
comorbidity and how the coordination of primary and
secondary care may have an impact on healthcare
costs.
INTRODUCTION
Comorbiditydthe simultaneous coexistence
of more than one health condition in
a single individualdi sc o m m o ni nt h e
general population and is particularly
frequent among primary care patients.
1
Polypharmacy is high among older people
who often suffer from comorbidity and from
having had many hospital admissions.
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ARTICLE SUMMARY
Article focus
- Comorbidity is often associated with high health-
care costs and raises questions that are of
interest for the organisation of primary and
secondary healthcare, for example, what is the
impact on healthcare costs?
- Is there an increase in costs because the
complexity is high in the management of the
different diseases? Or maybe there is a decline in
costs due to an efﬁcient handling and therefore
a lower numbers of healthcare contacts for single
persons with many diseases?
Key messages
- The comorbidity inﬂuence on healthcare costs
tended to be lessdnot moredthan additive and
among patients with back pain and depression,
signiﬁcantly less than additive.
Strengths and limitations of this study
- The possibility to measure total healthcare
utilisation on an individual level both in primary
care and hospital care was an advantage in this
study.
- There are broad clinical variations in register
data, for instance variations in the deﬁnition of
diagnoses. An under-reporting of diagnoses in
the medical records is common, especially in
primary care.
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Open Access ResearchComorbidity has shown to increase with the number of
chronic conditions.
4 High healthcare costs raise ques-
tions that are of interest for health services research, for
example, What is the impact on healthcare costs? Is
there an increase in costs because the complexity is high
in the management of the different diseases? Or maybe
there is a decline in costs due to several diseases in one
patient being treated at the same consultation resulting
in lower numbers of healthcare contacts than expected
for single persons with many diseases? Little data exist
how chronic health conditions cluster. The impact of
combinations of chronic condition on healthcare
utilisation and healthcare costs are poorly understood.
There is little information about speciﬁc chronic
conditions on healthcare costs.
5
The purpose of this study was to analyse how comor-
bidity among patients with back pain, depression and
osteoarthritis inﬂuences healthcare costs per patient.
A special focus was made on the distribution of costs
for primary healthcare compared with specialist care,
hospital care and drugs. It has been stated that a better
coordination of care may reduce hospitalisation rated,
especially for persons with multiple chronic condi-
tions.
4 Analyses of comorbidity effects were from the
perspective of healthcare professionals, that is, based
on diagnoses. We have chosen the diagnoses depres-
sion, back pain and osteoarthritis because all these
health states are frequent problems both in primary
care and in specialist care. Prior studies have reported
a relatively large share of mental health conditions in
patients with back pain.
6e10 Clinical associations
between osteoarthritis and depression have seldom
been reported.
METHODS
Data sources
Statistics Sweden has created a total population register
for the country. This register is mainly used as a basic
register for preparation of statistics in the Swedish
counties and municipalities regarding the size and
composition of their populations stratiﬁed according to
sex, age, educational status, etc. In this population-based
study, we linked the population register to different
registers of the residents of the County of O ¨ stergo ¨tland,
situated in south-east Sweden. Individual data on clinical
diagnosis, age, gender, socioeconomic status (educa-
tion), drug prescriptions, drug costs and healthcare costs
(primary care and hospital care) were made available,
from these registers, for the whole population of the
county. Education was used to express socioeconomic
status. In a former study where we used the same data
register, it was shown that education was an adequate
covariate in this age interval.
11 The personal identiﬁca-
tion numbers for people living in Sweden facilitate
linking information from different registers. All indi-
viduals between 20 and 75 years of age, who were resi-
dents of the County of O ¨ stergo ¨tland in year 2006, were
included in the comorbidity analysis.
Healthcare utilisation and diagnoses
Healthcare contacts were collected with the help of The
Care Data Warehouse in O ¨ stergo ¨tland.
12 This register
consists of administrative records of all publicly ﬁnanced
healthcare utilisation in the county, including inpatient
and outpatient care for all medical specialties (the
register includes more than 95% of the healthcare
utilisation in the county).
All healthcare utilisation per patient during year 2006
was extracted and expressed by the following variables:
total number of hospital days, total number of visits in
outpatient care including physician visits (hospital
outpatient visits, general practitioner (GP) visits) and
visits to paramedical staff.
Using the information registered at all healthcare
contacts in the year of 2006, individuals were classiﬁed as
having depression if they at least once had a diagnosis of
depression (F32eF39 according to the International
Classiﬁcation of Diseases, 10th version (ICD-10)). In
a similar way, individuals were deﬁned as having osteo-
arthritis (M15eM19) or back pain (M50eM54).
To be able to adjust for the effect of other conditions
besides those of interest to the study, the number of
other health conditions was calculated as the number of
other diagnoses registered for each individual in 2006
with a limit of one diagnosis per ICD-10 chapter (and
excluding the entire F-chapter ‘mental disorders’ as well
as the back pain and osteoarthritis subsections of the
M-chapter ‘musculoskeletal disorders’).
Healthcare costs
The cost per patient (CPP) database of the O ¨ stergo ¨tland
County Council contains data on costs for each patient
utilising the healthcare system.
12 In the CPP database,
clinic-speciﬁc costs are estimated for all healthcare
services, for example, a visit to a physician, a nurse or
laboratory tests Thus, it was possible, for example, to
summarise the CPP for healthcare in different clinics
and for each individual over the years 2006 and 2007.
Previous studies have proven its use in research.
13
We added drug costs from the Swedish Prescribed
Drug Register.
14 The Drug Register contains records of
all dispensed drug prescriptions and covers the whole
Swedish population. Measurement units of utilisation
are the number of prescriptions, deﬁned daily doses and
expenditures. The register contains data on drugs (the
prescribed and dispensed amount per item and drug
costs per individual). In this study, all drugs dispensed to
residents in the County of O ¨ stergo ¨tland during 2006 and
2007 were included.
Three different kinds of costs were used in the anal-
ysis: primary care costs, hospital costs (inpatient and
outpatient) and drug costs. All costs were on an indi-
vidual basis and noted in SEK (2007).
Statistical methods
To examine how the different diagnoses affected health-
care costs (primary healthcare costs, hospital costs, drug
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Comorbidity and healthcare costscosts and total costs, respectively), multiple linear
regression models were ﬁtted with each of the diagnosis
included as a dichotomous factor. The comorbidity effects
on costs were estimated by including all two-way interac-
tion terms between the diagnoses (depression 3 osteo-
arthritis, depression 3 back pain and osteoarthritis 3
back pain). A positive interaction term indicates that the
comorbidity effect on costs is more than additive and
a negative term indicates a less than additive effect on
costs. Since the variability in costs was higher in patient
groups with higher mean costs, we used robust estimation
of SEs of the regression coefﬁcients.
15 As there were
differences in age, gender, number of other health
conditions and education between the diagnoses groups
(table 1), all regression models also included these factors
as covariates.
16
Ethics
Conﬁdentiality was ensured by one-way encrypted
ID-numbers. The study was approved by the Regional
Ethical Review Board in Linko ¨ping.
RESULTS
Characteristics of the study population (266354
persons) are summarised in table 1. The largest diag-
nosed group was back pain (11178 patients) followed by
depression (7412 patients) and osteoarthritis (5174
patients). Older patients dominated in the osteoarthritis
group, and the youngest patients were found in the
depression group. The average number of other health
conditions for the comorbidity groups was between two
and three times higher compared with the total popu-
lation. Total mean CPP with a depression diagnosis was
SEK 36904 (primary care SEK 5715, hospital care SEK
25633, drugs SEK 5557). The largest comorbidity
subgroup was the combination of back pain and
depression (772 patients), followed by the combination
of back pain and osteoarthritis (527 patients) and the
combination of depression and osteoarthritis (206
patients).
In order to analyse how the combinations of diagnoses
inﬂuence healthcare costs (primary healthcare costs,
hospital costs and drug costs), multiple regression
models were ﬁtted (table 2). For patients having both
a depression diagnosis and a back pain diagnosis, there
was a signiﬁcant negative interaction effect on total
healthcare costs, which indicates that the average total
healthcare costs among patients with a depression diag-
nosis and a back pain diagnosis were signiﬁcantly lower
when one patient had both diagnoses compared with
two patients having one diagnosis each. Thus, the
average healthcare costs associated with depression and
back pain was estimated to SEK 28456 (22004+6452)
when these two diagnoses were not in same patient,
while it was SEK 11806 lower for a patient with both
diagnoses. Signiﬁcant negative interactions between
depression and back pain were also observed for hospital
and drug costs.
Small or no interactions at all were seen between
depression diagnoses and osteoarthritis diagnoses
(table 2). For the comorbidity group consisting of oste-
oarthritis and back pain, there was a positive, not
signiﬁcant, interaction for drug costs.
Costs in primary care and specialist outpatient care
were associated with the number of physician visits.
Therefore, multiple regression models were used to
Table 1 Characteristics of the study population and diagnoses groups (2006)
Total
population Depression Osteoarthritis Back pain Dep and BP Dep and Arth Arth and BP
n 266354 7712 5174 11178 772 208 527
Gender
Male 51.0 33.1 40.0 42.6 69.8 78.8 63.9
Female 49.0 66.9 60.0 57.4 30.2 21.2 36.1
Age, years
20e45 47.0 47.4 6.3 38.3 39.2 8.2 8.3
46e65 39.7 41.1 54.9 47.6 48.4 58.7 59.0
66e75 13.3 11.5 38.8 14.1 12.3 32.2 32.6
Education
Primary 20.9 23.7 34.4 27.9 29.0 36.5 39.1
Secondary 49.4 50.5 44.8 53.0 52.1 40.9 45.4
University 29.6 25.8 20.7 19.2 18.9 21.6 15.6
No. of other
conditions (mean)
1.13 1.90 2.33 2.01 2.63 3.08 3.05
Mean costs (2007)
Primary care 1816 5715 6936 5988 9045 10033 9481
Hospital care 7155 25633 22544 15950 30607 34202 27736
Drug 2020 5557 5566 4215 7257 9384 8043
Total 10990 36904 35046 26152 46909 53619 45620
Per cent and mean costs (SEK 2007).
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Comorbidity and healthcare costsanalyse how the combination of diagnoses affected the
number of visits to healthcare (table 3). The combina-
tion of depression and back pain showed a positive
interaction for GP visits, but there were negative inter-
actions for all other visits.
DISCUSSION
The total healthcare costs among patients with
a depression diagnosis and a back pain diagnosis were
signiﬁcantly lower when one patient had both diagnoses
compared with two patients having one diagnosis each.
Table 2 Comorbidity effects on healthcare costs as estimated by multiple linear regression models (interactions)
Primary HC costs Hospital costs Drug costs Total costs
Intercept 20651 9176295** 533665*** 14306326***
Gender
Female Ref Ref Ref Ref
Male 198627*** 16846171*** 345651*** 18306192***
Age, years
20e45 Ref Ref Ref Ref
46e65 511621*** 7426163*** 783652*** 20366182***
66e75 1565666*** 35046337*** 1341674 64116373***
Education
Primary Ref Ref Ref Ref
Secondary 295644*** 15496260*** 228656*** 20726286***
University 528642*** 21116262*** 341659*** 29806288***
No. of other conditions 1385623*** 64666129*** 1789633*** 96416144***
Diagnosis
Depression 27466161*** 1662161173*** 26366149*** 2200461244***
Osteoarthritis 28496160*** 67506830*** 8256192*** 104256940***
Back pain 2886693*** 30676524*** 4996112*** 64526581***
Interactions
Depression and osteoarthritis 145±1443 L1890±7091 201±897 L1544±7741
Depression and back pain L659±609 L9779±3200** L1369±575* L11806±3572***
Osteoarthritis and back pain L751±558 L2225±3159 874±794 L2101±3616
Regression coefﬁcients 6 SE.
*p<0.05, **p<0.01, ***p<0.001. Regression coefﬁcients showing the comorbidity effects are highlighted using bold values.
Table 3 Comorbidity effects on healthcare visits as estimated by multiple linear regression models (interactions)
GP Hospital specialists
Paramedical,
primary care Paramedical hospital
Intercept 0.6860.010*** 0.3860.024*** 0.5460.071*** 1.6060.055***
Gender
Female Ref Ref Ref Ref
Male 0.2360.006*** 0.0160.017 0.1660.039*** 0.6760.030***
Age, years
20e45 Ref Ref Ref Ref
46e65 0.0760.006*** 0.0260.013 0.5760.028*** 0.4460.033***
66e75 0.1860.011*** 0.2460.027*** 2.1760.084*** 0.6560.050***
Education
Primary Ref Ref Ref Ref
Secondary 0.0560.009*** 0.1160.023*** 0.5160.063*** 0.1660.045***
University 0.1660.009*** 0.0860.024** 0.7860.063*** 0.1960.046***
No. of other conditions 0.3360.003*** 0.6360.014*** 0.9460.031*** 0.7260.018***
Diagnosis
Depression 0.5760.029*** 0.6560.070*** 1.6060.267*** 3.8160.242***
Osteoarthritis 0.3960.031*** 0.3560.053*** 1.6260.173*** 0.6960.144***
Back pain 0.6660.021*** 0.1560.042*** 1.1260.104*** 0.8060.094***
Interactions
Depression and osteoarthritis L0.03±0.229 L0.35±0.321 0.31±1.591 1.61±3.222
Depression and back pain 0.32±0.178 L0.27±0.202 L0.36±0.753 L1.45±0.645*
Osteoarthritis and back pain L0.14±0.116 0.09±0.194 0.24±0.585 0.30±0.821
Regression coefﬁcients 6 SE.
*p<0.05, **p<0.01, ***p<0.001. Regression coefﬁcients showing the comorbidity effects are highlighted using bold values.
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Comorbidity and healthcare costsThis decrease of costs was largely related to hospital care,
while the number of GP visits showed an increase. The
combination of osteoarthritis and back pain had no
signiﬁcant reduction in healthcare costs. No signiﬁcant
interactions were found between the diagnoses, osteo-
arthritis and depression. However, the drug costs for
patients with both osteoarthritis and back pain were
higher (but non-signiﬁcant) compared with the
expected costs for the separate diagnoses.
Valderas et al
1 have mentioned three ways in which
different diseases may be found in the same person: by
chance, selection bias and by different kinds of causal
association.
In our total study population (266354), the prevalence
for a back pain diagnosis was 4.2% and for depression
2.9%. So by chance alone, about 330 persons
(0.02930.0423266354) would have both depression
and back pain. However, there were 772 persons with
both depression and back pain. Selection bias might be
an alternative explanation for this discrepancy. It is likely
that subjects already diagnosed as having one disease
tend to be detected in an earlier phase of another
disease since these patients will be under closer scrutiny,
a phenomenon known as Berkson’s bias.
17 There are
also possible reasons for a high prevalence of comor-
bidity due to causal association among patients with
a depression diagnosis and a back pain diagnosis.
Common underlying biopsychosocial conditions might
be involved. In the transition from acute to long-
standing pain, the inﬂuence of psychological factors, for
example, depression and anxiety, have been acknowl-
edged.
18 Prior studies have reported a relatively large
share of mental health conditions in patients with back
pain.
19 Both depression diagnosis and the back pain
diagnosis are based on the patients’ perceptions of
disease, and therefore, the methods used in the diag-
nostic processes for these diagnoses differ from the
more objective clinical methods used in diagnosing
osteoarthritis (x-ray). Moreover, mental illness and back
pain are common in middle-aged persons, while osteo-
arthritis is more frequent in the older people.
Different kinds of associations between the three
diagnoses were observed in earlier statistical analyses
from the same data records used in this study.
6 With
longitudinal data, we found that an episode of back pain
resulted in a higher hazard rate for depression. If
a person was given a back pain diagnosis, he/she had
a 46% risk of later getting a depression diagnosis.
However, little association was found between osteoar-
thritis and depression.
From other studies, it is known that many diseases, for
example, diagnoses in the gastrointestinal system and the
musculoskeletal system, are over-represented in patients
who receive antidepressant treatment.
20 A high level of
drug use, especially treatment with antidepressants, has
been found several years before a patient receiving
a depression diagnosis.
21 It might be possible that some
patients were presented with somatic complaints and
a depressive health status before the depression diagnosis
was made. Healthcare providers might have hesitated to
record a depression diagnosis and instead used a variety
of other diagnoses.
11 It is well known that chronic somatic
conditions and depression are associated.
Depression alone is a cause of increased morbidity and
mortality often associated with high healthcare costs, lost
work productivity and an increased total healthcare
utilisation.
8 Increased expenditures for other health
conditions before and after an incident of back pain in
the same individuals have been reported with, as
a consequence, an increase in healthcare costs.
9 Clinical
associations between osteoarthritis and depression have
not been reported, and no cost interactions were found
in our analyses between these health states.
Glynn et al
22 found, in a patient record review, that
healthcare utilisation and cost in both primary and
secondary care increased among patients with comor-
bidity. And costs increased with a higher number of
chronic conditions. The comorbidity effect occurred
independently of age, gender and socioeconomic status.
However, the study did not differentiate between
different kinds of diagnoses as we did in our study.
There might be some clinical reasons that interactions
between diagnoses inﬂuence healthcare costs, that is, the
costs tended to be lessdnot moredthan additive. We
found that the same kinds of drugs were used, to a very
high extent, in the treatment of both back pain and
depression. It is also possible that physicians could
manage several different health states (diagnoses) in the
same consultation. These circumstances might reduce
drug utilisation and the number of healthcare contacts
and thus the healthcare costs.
In our analyses, we found that patients with a back
pain diagnosis had a high share of GP visits compared
with patients with osteoarthritis who had relatively more
visits to hospital specialists. This fact might be one
explanation for the higher costs in primary care for
patients with depression and back pain. The high
frequency in GP visits was, however, followed by lower
numbers of other visits (paramedical staff and physi-
cians in special care), which on the other hand might be
a sign of less optimal paramedical care for this patient
group.
Patients with back pain diagnosis and depression
diagnosis, to a very high extent, received the same kind
of drug treatment. Hence, the top-ten list for drugs was
almost identical for the two diagnoses which could
explain the decrease in expected drug costs. However,
the same goes for the diagnoses of back pain and oste-
oarthritis, where this expected reduction in drug costs
was not seen.
Methodological considerations
The strengths of this study were the use of different
register databases and the linkage to other registers. The
possibility to follow total healthcare utilisation on an
individual level both in primary care and hospital care
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sources of bias such as recall bias and response bias
could be kept at a minimum. An additional strength was
the size of the study, with more than 11000 patients
having a back pain diagnosis, 7000 patients with
a depression diagnosis and 5000 patients with an osteo-
arthritis diagnosis. Some of the subgroups of comor-
bidity were, however, rather small in size, and SDs were
also larger. Hence, robust estimation of SEs of the
regression coefﬁcients was used. We did not include the
three-way interaction term (for those with all three
diagnoses) since there were only 46 patients of this kind
in the population, and with these types of highly variable
outcomes, the power for detecting even large effects in
this group was considered too low.
A weakness of using registers is the quality of data and
the broad clinical variation, for instance, variation in the
deﬁnition of depression. An under-reporting of diag-
noses in the medical records is common, especially in
primary care. Besides, it is possible that mental health
status may have been under-reported because of the
existence of comorbidity. Other health problems may
have been prioritised in the recording of the diagnoses.
Although patients with a depression diagnosis are
likely to be heavy users of healthcare, other factors
should be considered. Patients with low socioeconomic
status and female gender usually have a high use of
healthcare resources, and it is well known that women
have a high incidence and prevalence of depressive
disorders.
23 However, we adjusted for these potential
confounders.
Implications
The management, organisational structure and coordi-
nation of diagnoses in healthcare will have an impact on
healthcare costs.
In Sweden, there is no gatekeeping system but still it is
difﬁcult for a patient, without a referral from a GP, to see
a specialist in the hospital. A referral from a GP might
facilitate contacts with a specialist if there are precise
criteria for diagnosis and treatment which is the case in
diagnosing osteoarthritis. Thus, gatekeeping and
referral systems will inﬂuence the number of physician
visits at different healthcare levels.
National and regional guidelines also have an impact
on the localisation of care. For example, the new
Swedish guidelines for osteoarthritis in the knee and in
the hip encourage primary care to take a greater part of
the care for osteoarthritis.
24 The new guidelines will
probably change the distribution of healthcare costs
between hospital specialist care and primary care.
In hospital specialist care, there is often focus on
a single disease and no tradition for handling comor-
bidity. In our study, the osteoarthritis patients were
largely handled by hospital specialists. Hence, for this
patient group and its multimorbidities, there might
have been less coordination between the disease-
speciﬁc treatment and other healthcare treatments. In
the analyses, we found no cost reductions in the
combinations between osteoarthritis and the other two
diseases.
Patients with the two diagnoses, depression and back
pain, paid relatively more visits to primary care and many
of the healthcare visits included the paramedical
personnel. Therefore, depression and back pain were
handled to a great extent by GPs, and for these combi-
nations, signiﬁcant reductions in all types of costs were
seen. Hence, in the management of multimorbidities,
there might be opportunities for coordinating these
healthcare processes within primary care in order to
reduce costs.
25 The coordination of care among persons
with multiple health conditions is also important for the
quality of care and to avoid unnecessary hospitalisations.
A better primary care will be essential in this coordina-
tion process.
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Conclusions
The comorbidity inﬂuence on healthcare costs tended to
be lessdnot moredthan additive and among patients
with back pain and depression, signiﬁcantly less than
additive. Further studies are needed to clarify conditions
for an effective healthcare for patients with comorbidity.
There are different ways of organising healthcare in
other countries. International comparisons with the
same kind of diagnoses used in this study might be of
interest in future research in order to evaluate potential
additive effects. Can our ﬁnding of opposite comorbidity
effects for depression and back pain on GP visits and
hospital costs be replicated in other healthcare systems?
The coordination between primary and secondary care
and the ﬁnancial responsibility for diseases within
healthcare will have an impact on healthcare costs. A
primary healthcare responsibility for the whole health-
care process might be one way to reduce total healthcare
costs where comorbidity is involved.
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